Jevtana: Package Insert and Label Information (Page 5 of 5)

PRINCIPAL DISPLAY PANEL — Kit Carton

NDC 0024-5824-11
Rx only

JEVTANA®
(cabazitaxel)
Injection

60 mg/1.5 mL Before First Dilution*

FOR INTRAVENOUS INFUSION ONLY AFTER SECOND DILUTION
*Requires two dilutions before administration. See back panel for details.

Warning: Cytotoxic Agent

Carton Contains:
One single-dose JEVTANA vialOne single-dose Diluent vial

SANOFI

PRINCIPAL DISPLAY PANEL -- Kit Carton
(click image for full-size original)
JEVTANA cabazitaxel kit
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0024-5824
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0024-5824-11 1 KIT in 1 CARTON None
Quantity of Parts
Part # Package Quantity Total Product Quantity
Part 1 1 VIAL, GLASS 5.7 mL
Part 2 1 VIAL, GLASS 5.7 mL
Part 1 of 2
JEVTANA cabazitaxel injection, solution, concentrate
Product Information
Item Code (Source) NDC:0024-5823
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
cabazitaxel (cabazitaxel) cabazitaxel 60 mg in 1.5 mL
Inactive Ingredients
Ingredient Name Strength
Polysorbate 80 1.56 g in 1.5 mL
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0024-5823-15 5.7 mL in 1 VIAL, GLASS None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA201023 06/17/2010
Part 2 of 2
DILUENT alcohol and water injection
Product Information
Item Code (Source) NDC:0024-5822
Route of Administration INTRAVENOUS DEA Schedule
Inactive Ingredients
Ingredient Name Strength
alcohol
water
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0024-5822-01 5.7 mL in 1 VIAL, GLASS None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA201023 06/17/2010
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA201023 06/17/2010
Labeler — Sanofi-Aventis U.S. LLC (824676584)
Establishment
Name Address ID/FEI Operations
Sanofi Chimie 291592785 ANALYSIS (0024-5824), API MANUFACTURE (0024-5824)
Establishment
Name Address ID/FEI Operations
Sanofi-Aventis Deutschland GmbH 313218430 ANALYSIS (0024-5824), LABEL (0024-5824), MANUFACTURE (0024-5824), PACK (0024-5824)

Revised: 02/2021 Sanofi-Aventis U.S. LLC

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2022. All Rights Reserved.